Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Achieved statistical significance on primary endpoint at Week 12 on mean change from baseline DAS-28 CRP across all rosnilimab doses vs.

BRANFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immunotherapy company developing first-in-category, multifunctional T Cell engager biotherapeutics to address unmet ...

Research from Umeå University paves the way for a quantitative data analysis method to study the cell division process in ...

The immunotherapy used in the trial was nivolumab ( Opdivo ), a drug delivered intravenously that works by disabling a ...

Fresh off of winning five Grammy Awards, including song and record of the year for his hit “Not Like Us,” Lamar is the ...

A rugby player from Bristol has died at the age of 27 following a battle with leukaemia. Old Redcliffians player Ellis Joseph ...

Breaking down large battery packs involves a three-step shredding process, which reduces individual battery cells to 5/8-inch ...

Two Islamic State (IS) militants were killed in an airstrike in the northern Iraqi province of Kirkuk, the Iraqi military ...

Doug Kellogg, professor of molecular, cell, and developmental biology at UC Santa Cruz, has been awarded $2.95 million from ...

Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing ...